期刊文献+

食管癌组织中血管生成素样蛋白3及MVD的表达 被引量:1

Expression of ANGPTL3 and microvessel density in esophageal carcinoma
下载PDF
导出
摘要 目的:研究食管癌组织中血管生成素样蛋白3(ANGPTL3)的表达情况及其与血管生成的关系。方法:应用免疫组化SP法检测52例食管癌组织(TNMⅠ期21例,Ⅱ期17例,Ⅲ期14例)和相应正常食管组织中AN-GPTL3的表达,同时检测了微血管密度(MVD)。结果:正常食管组织和食管癌组织中ANGPTL3蛋白的阳性表达率差异有统计学意义(χ2=31.243,P<0.001)。Ⅲ期食管癌组织中ANGPTL3的阳性表达率(92.9%,13/14)高于Ⅰ期(57.1%,12/21)、Ⅱ期(82.4%,14/17)患者,差异有统计学意义(χ2=6.443,P=0.040)。食管癌组织中MVD为47.2±6.7。随着肿瘤期别的增加,MVD>47.2的例数也随之增多(χ2=7.648,P=0.022)。食管癌组织中AN-GPTL3蛋白表达与MVD(MVD>47.2)呈正关联关系(rP=0.484,P<0.001)。结论:食管癌组织中ANGPTL3高表达是肿瘤血管生成的重要因素。 Aim:To investigate the expression of angiopoientin-like protein 3(ANGPTL3)and its relationship with the angiogenesis in esophageal carcinoma.Methods:The expression of ANGPTL3 and the microvessel density(MVD) in 52 specimens of esophageal carcinoma(TNM stages:Ⅰ 21 cases,Ⅱ 17 cases,Ⅲ 14 cases) and corresponding normal esophageal tissues were detected by SP immunohistochemistry.Results:Significant difference expression of ANGPTL3 was noted between the groups of normal esophageal tissue and esophageal carcinoma tissue(χ2=31.243,P0.001).The positive rate of ANGPTL3 in Ⅲ stage(92.9%,13/14)was obviously higher than that inⅠstage(57.1%,12/21)and Ⅱstage(82.4%,14/17).The difference was statistically significant(χ2=6.443,P=0.040).The MVD was 47.2±6.7 in esophageal carcinoma tissue,and the cases with MVD47.2 was more with advance of TNM stages(χ2=7.648,P=0.022).There were positively relationship between the expression of ANGPTL3 and MVD in esophageal carcinoma(rP=0.484,P0.001).Conclusion:High expression of ANGPTL3 may play an important role in tumor angiogenesis of esophageal carcinoma.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第5期723-726,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 食管癌 血管生成素样蛋白3 微血管密度 esophageal carcinoma angiopoientin-like protein 3 MVD
  • 相关文献

参考文献3

二级参考文献36

  • 1文卫,杨连粤,黄耿文,杨治力,刘合利,杨建青.TSP-1和VEGF在肝细胞癌新生血管生成中的作用[J].中华肝胆外科杂志,2005,11(1):17-19. 被引量:19
  • 2[7]Pertovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor beta in fibroblastic and epithelial cells[J]. Biol Chem, 1994,269(9):6271-6274.
  • 3[8]Gold LI. The role for transforming growth factor-beta (TGF beta) in human cancer [J]. Crit Rev Oncog, 1999,10(4):303-360.
  • 4[9]Hasegawa Y, Takanashi S, Kanehira Y, et al. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma [J]. Cancer, 2001,91(5):964-971.
  • 5[10]Pepper MS, Vassalli JD, Orci L, et al. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis[J]. Exp Cell Res, 1993, 204 (2): 356-363.
  • 6[1]Srivastava A, Laidler P, Katmar M, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study[J]. Am J Pathol, 1988,133(2):419-423.
  • 7[2]Waltenberger J, Claesson-Welsh L, Siegbahn A, et al. Different signal transduction of KDR and Flt1, two receptors for vascular endothelial growth factor [J]. J Biol Chem, 1994,269(43):26988-26995.
  • 8[3]Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis[J]. Nature,1992,359(6398): 843-845.
  • 9[4]Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma [J]. Clin Cancer Res, 1997,3(6):861-865.
  • 10[5]Shibusa T, Shijubo N, Abe S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma [J]. Clin Cancer Res, 1998,4(6):1483-1487.

共引文献90

同被引文献15

  • 1Klauber N, Rohan RM, Flynn E, et al. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470[J]. Nat Med, 1997, 39 (4): 443-446.
  • 2Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin Tie system [J]. Nat Rev Mol Cell Biol, 2009, 10 (3): 165- 177.
  • 3Parborell F, Abramovich D, Irusta G, et al. Angiopoietin 1 reduces rat follicular atresia mediated by apoptosis through the PI3K/Akt pathway [J].Mol Cel Endocrinol, 2011,343 (1/2), 79-87.
  • 4Parborell F, Abramovich D, Tesone M. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes [J].Biol Reprod, 2008, 78 (3): 506- 513.
  • 5Robinson RS, Woad KJ, Hammond AJ, et al. Angiogenesis and vascular function in the ovary [J]. Reproduction, 2009, 138 (6):869-881.
  • 6Hayashi KG, Acosta TJ, Tetsuka M, et al. Involvement of angiopoietin tie system in bovine follicular development and atresia: messenger RNA expression in the cainterna and effect on steroid secretion [J]. Biol Reprod, 2003, 69 (6)~ 2078- 2084.
  • 7Chowdhury MWH, Scaramuzzi RJ, Wheeler-Jones CPD, et al. The expression of angiogenic growth factors and theirreceptors in ovarian follicles throughout the estrous cycle in the ewe[J].Theriogenology, 2010, 73 (7): 856 872.
  • 8ShimizuT, Berisha B, Schams D, et al. Expression of angiopoietin (ANPT) 1, ANPT-2 and their receptors in dominant follicles during periovulatory period in GnRH treated cow [J]. ReprodDomestAnim, 2007, 42 (2): 221-224.
  • 9Xu F, Stouffer RL. Local delivery of angiopoietin-2 into the preovulatory folliele terminates the menstrual cycle in rhesus monkeys [J]. BiolReprod, 2005, 72 (6): 1352-1358.
  • 10Hurliman AK, Speroff L, Stouffer RL, et al. Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation [J].Fertil Steril, 2010, 93 (5).- 1493-1499.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部